Form 4 for MRNA Moderna
Accepted 2021-12-29 00:00:00 ET · period of report 2021-12-27 · accession 0001127602-21-031988 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-29 | 2021-12-27 | MRNA | Hoge Stephen | Pres | M - OptEx | $10.90 | +5,000 | 1.61M | +0.3% | +$54.5K |
| D | 2021-12-29 | 2021-12-27 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $243.10 | -5,000 | 1.61M | -0.3% | -$1.22M |
| D | 2021-12-29 | 2021-12-27 | MRNA | Hoge Stephen | Pres | M - OptEx | $0.00 | -5,000 | 167.0K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-27 | M | A | 5,000 | $10.90 | 1,614,597 | D | — | — | |
| 2 | Common | Common Stock | 2021-12-27 | S | D | 5,000 | $243.10 | 1,609,597 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2021-12-27 | M | D | 5,000 | $0.00 | 166,972 | D | $10.90 · — to 2026-02-23 | 5,000 Common Stock | (F3) This option is fully vested and exercisable. |